Literature DB >> 8695821

Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera.

H Segall1, I Lubin, H Marcus, A Canaan, Y Reisner.   

Abstract

Severe combined immunodeficient (SCID) mice are increasingly used as hosts for the adoptive transfer of human lymphocytes. Human antibody responses can be obtained in these xenogeneic chimeras, but information about the functionality of the human T cells in SCID mice is limited and controversial. Studies using human peripheral blood lymphocytes (PBL) injected intraperitoneally (IP) into SCID mice (hu-PBL-SCID mice) have shown that human T cells from these chimeras are anergic and have a defective signaling via the T-cell receptor. In addition, their antigenic repertoire is limited to xenoreactive clones. In the present study, we tested the functionality of human T cell in a recently described chimeric model. In this system, BALB/c mice are conditioned by irradiation and then transplanted with SCID bone marrow, followed by IP injection of human PBL. Our experiments demonstrated that human T cells, recovered from these hu-PBL-BALB mice within 1 month posttransplant, proliferated and expressed activation markers upon stimulation with anti-CD3 monoclonal antibody. A vigorous antiallogeneic human cytotoxic T-lymphocyte (CTL) response could be generated in these mice by immunizing them with irradiated allogeneic cells. Moreover, anti-human immunodeficiency virus type 1 (HIV-1) Net-specific human CTLs could be generated in vivo from naive lymphocytes by immunization of mouse-human chimeras with a recombinant vaccinia-nef virus. This model may be used to evaluate potential immunomodulatory drugs or cytokines, and could provide a relevant model for testing HIV vaccines, for production of antiviral T-cell clones for adoptive therapy, and for studying human T-cell responses in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695821

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Human T cells recovered from human/Balb radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection.

Authors:  O Shapira-Nahor; H Marcus; H Segall; I Lubin; S Slavin; A Panet; Y Reisner
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

2.  Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.

Authors:  W O Böcher; H Marcus; R Shakarchy; B Dekel; D Shouval; E Galun; Y Reisner
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

3.  Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge.

Authors:  Santhi Gorantla; Kathlyn Santos; Vakara Meyer; Stephen Dewhurst; William J Bowers; Howard J Federoff; Howard E Gendelman; Larisa Poluektova
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.

Authors:  T Cao; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

5.  CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.

Authors:  Santhi Gorantla; Edward Makarov; Jennifer Finke-Dwyer; Catherine L Gebhart; William Domm; Stephen Dewhurst; Howard E Gendelman; Larisa Y Poluektova
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

6.  Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system.

Authors:  R Eren; I Lubin; D Terkieltaub; O Ben-Moshe; A Zauberman; R Uhlmann; T Tzahor; S Moss; E Ilan; D Shouval; E Galun; N Daudi; H Marcus; Y Reisner; S Dagan
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

7.  Human/BALB radiation chimera engrafted with splenocytes from patients with idiopathic thrombocytopenic purpura produce human platelet antibodies.

Authors:  B Dekel; H Marcus; B Shenkman; A Shimoni; Y Shechter; A Canaan; A Berrebi; D Varon; Y Reisner
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

Review 8.  Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy.

Authors:  Arvind Chhabra
Journal:  Front Immunol       Date:  2017-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.